Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Panel Reactive Antibody”

24 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 24 results

Large-scale testing (Phase 3)Active Not RecruitingNCT05369975
What this trial is testing

Efficacy and Safety in Imlifidase Desensitized Kidney Tx Patients, Including Two Non-Comparative Reference Cohorts

Who this might be right for
Kidney Transplantation in Highly Sensitized Patients
Hansa Biopharma AB 225
Not applicableEnded earlyNCT00586716
What this trial is testing

Intravenous Immune Globulin (IVIG) Treatment Protocol in Kidney Transplant Patients

Who this might be right for
End Stage Renal Disease
Loma Linda University 22
Post-approval studies (Phase 4)Study completedNCT00784979
What this trial is testing

Panel Reactive Antibody (PRA) Reduction in Sensitized Patients Awaiting Renal Transplantation

Who this might be right for
End Stage Renal Disease
Tampa General Hospital 26
Early research (Phase 1)WithdrawnNCT00476515
What this trial is testing

Rituximab Therapy for Patients on Kidney Transplant Waiting List With Positive Donor Specific Crossmatch to Living Donor

Who this might be right for
Kidney Insufficiency
Massachusetts General Hospital
Testing effectiveness (Phase 2)Active Not RecruitingNCT04827979
What this trial is testing

Daratumumab and Belatacept for Desensitization

Who this might be right for
Highly Sensitized Prospective Kidney Transplant Recipients
National Institute of Allergy and Infectious Diseases (NIAID) 19
Large-scale testing (Phase 3)Study completedNCT00693576
What this trial is testing

The Effect of Simvastatin on Desensitization of Panel-Positive Kidney Transplant Candidates

Who this might be right for
Renal Transplantation
Shiraz University of Medical Sciences 82
Not applicableStudy completedNCT01135485
What this trial is testing

Evaluation of Panel Reactive Antibody in Children Following Stage I Palliation for Hypoplastic Left Heart Syndrome

Who this might be right for
Congenital Heart Disease
University of Pennsylvania 33
Large-scale testing (Phase 3)Study completedNCT04935177
What this trial is testing

Renal Function in Highly Sensitized Patients 1 Year After Desensitization With Imlifidase Prior to DD Kidney Tx

Who this might be right for
Kidney Transplantation in Highly Sensitized Patients
Hansa Biopharma AB 64
Testing effectiveness (Phase 2)Study completedNCT00670774
What this trial is testing

Dosing Regimen of Eculizumab Added to Conventional Treatment in Positive Cross Match Living Donor Kidney Transplant

Who this might be right for
Kidney Transplant
Mark Stegall 31
Not applicableEnded earlyNCT01334281
What this trial is testing

An In-vitro Standardization of B Cell Elispot Assays

Who this might be right for
Transplant SensitizationPanel Reactive AntibodySensitization to HLA Antigens
Northwestern University 19
Testing effectiveness (Phase 2)Ended earlyNCT01106027
What this trial is testing

Dosing Regimen of Eculizumab Added to Conventional Treatment in Positive Crossmatch Deceased Donor Kidney Transplant

Who this might be right for
Kidney Transplant
Mayo Clinic 2
Testing effectiveness (Phase 2)WithdrawnNCT03593421
What this trial is testing

Phase 2 Dose Finding sPIF in Patients With High Panel Reactive Antibodies

Who this might be right for
Panel Reactive Antibodies
Christopher O'Brien, MD
Testing effectiveness (Phase 2)Study completedNCT02790437
What this trial is testing

A Phase II Study to Evaluate the Efficacy of IdeS to Desensitize Transplant Patients With a Positive Crossmatch Test

Who this might be right for
Kidney Failure, Chronic
Hansa Biopharma AB 19
Not applicableActive Not RecruitingNCT05714514
What this trial is testing

Survival and Dialysis Independency in Highly Sensitized Patients After Desensitization With Imlifidase and Tx of Kidneys

Who this might be right for
Kidney Transplantation in Highly Sensitized Patients
Hansa Biopharma AB 64
Testing effectiveness (Phase 2)Looking for participantsNCT05753930
What this trial is testing

Imlifidase Prior to Kidney Transplant in Highly Sensitised Children

Who this might be right for
Kidney Transplantation in Highly Sensitized Patients
Hansa Biopharma AB 10
Large-scale testing (Phase 3)Study completedNCT00275509
What this trial is testing

Induction Therapy Study in Live Donor Kidney Transplant Recipients With a Positive Crossmatch

Who this might be right for
Kidney Failure, Chronic
Johns Hopkins University 56
Early research (Phase 1)Study completedNCT00143741
What this trial is testing

Use of Atorvastatin (Lipitor) to Decrease Panel Reactive Antibody Titers

Who this might be right for
End-Stage Kidney Disease
University of Chicago 20
Testing effectiveness (Phase 2)Ended earlyNCT05049850
What this trial is testing

Investigate DSA Rebound in Patients Treated With Imlifidase Prior to Transplantation

Who this might be right for
Kidney Transplantation in Highly Sensitized Patients
Hansa Biopharma AB 3
Not applicableWithdrawnNCT00460824
What this trial is testing

A Retrospective Review - Anti-HLA Antibodies

Who this might be right for
Congenital Disorders
Emory University
Large-scale testing (Phase 3)Study completedNCT02013037
What this trial is testing

The De-novo Use of Eculizumab in Presensitized Patients Receiving Cardiac Transplantation

Who this might be right for
Antibody-mediated RejectionHyperacute Rejection of Cardiac TransplantLeft Ventricular Dysfunction+2 more
Cedars-Sinai Medical Center 36
Load More Results